Literature DB >> 25267421

Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

Roland E Schmieder1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25267421     DOI： 10.1038/nrcardio.2014.70-c2

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; George L Bakris
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

2.  Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?

Authors:  Roland E Schmieder
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

3.  From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?

Authors:  Atul Pathak; Sebastian Ewen; Jean Fajadet; Benjamin Honton; Felix Mahfoud; Jean Marco; Markus Schlaich; Roland Schmieder; Konstantinos Tsioufis; Christian Ukena; Thomas Zeller
Journal:  EuroIntervention       Date:  2014-05       Impact factor: 6.534

4.  Ethnicity and sympathetic tone: predictors of the blood pressure response to renal denervation?

Authors:  Yutang Wang
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

5.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

6.  Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.

Authors:  Murray D Esler; Michael Böhm; Horst Sievert; Christian L Rump; Roland E Schmieder; Henry Krum; Felix Mahfoud; Markus P Schlaich
Journal:  Eur Heart J       Date:  2014-06-04       Impact factor: 29.983

7.  Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.

Authors:  Felix Mahfoud; Christian Ukena; Roland E Schmieder; Bodo Cremers; Lars C Rump; Oliver Vonend; Joachim Weil; Martin Schmidt; Uta C Hoppe; Thomas Zeller; Axel Bauer; Christian Ott; Erwin Blessing; Paul A Sobotka; Henry Krum; Markus Schlaich; Murray Esler; Michael Böhm
Journal:  Circulation       Date:  2013-06-18       Impact factor: 29.690

8.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

9.  Blood pressure changes after renal denervation at 10 European expert centers.

Authors:  A Persu; Y Jin; M Azizi; M Baelen; S Völz; A Elvan; F Severino; J Rosa; A Adiyaman; F E Fadl Elmula; A Taylor; A Pechère-Bertschi; G Wuerzner; F Jokhaji; T Kahan; J Renkin; M Monge; P Widimský; L Jacobs; M Burnier; P B Mark; S E Kjeldsen; B Andersson; M Sapoval; J A Staessen
Journal:  J Hum Hypertens       Date:  2013-09-26       Impact factor: 3.012
  9 in total
  5 in total

Review 1.  Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Authors:  Christian Ott; Roland E Schmieder
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

2.  Renal denervation in hypertensive patients not on blood pressure lowering drugs.

Authors:  Rosa L De Jager; Margreet F Sanders; Michiel L Bots; Melvin D Lobo; Sebastian Ewen; Martine M A Beeftink; Michael Böhm; Joost Daemen; Oliver Dörr; Dagmara Hering; Felix Mahfoud; Holger Nef; Christian Ott; Manish Saxena; Roland E Schmieder; Markus P Schlaich; Wilko Spiering; Pim A L Tonino; Willemien L Verloop; Eva E Vink; Evert-Jan Vonken; Michiel Voskuil; Stephen G Worthley; Peter J Blankestijn
Journal:  Clin Res Cardiol       Date:  2016-04-22       Impact factor: 5.460

3.  Renal Artery Vasodilation May Be An Indicator of Successful Sympathetic Nerve Damage During Renal Denervation Procedure.

Authors:  Weijie Chen; Huaan Du; Jiayi Lu; Zhiyu Ling; Yi Long; Yanping Xu; Peilin Xiao; Laxman Gyawali; Kamsang Woo; Yuehui Yin; Bernhard Zrenner
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

4.  Perivascular radiofrequency renal denervation lowers blood pressure and ameliorates cardiorenal fibrosis in spontaneously hypertensive rats.

Authors:  Shujie Wei; Dan Li; Yan Zhang; Linan Su; Yunrong Zhang; Qiang Wang; Dachun Yang; Yongjian Yang; Shuangtao Ma
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

5.  Acupuncture Attenuates Renal Sympathetic Activity and Blood Pressure via Beta-Adrenergic Receptors in Spontaneously Hypertensive Rats.

Authors:  Jing-Wen Yang; Yang Ye; Xue-Rui Wang; Fang Li; Ling-Yong Xiao; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Neural Plast       Date:  2017-02-08       Impact factor: 3.599
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.